120 related articles for article (PubMed ID: 14752999)
1. [Comments to the brochure "Genetic tests and drug monitoring" distributed by the Laboratoriet, Epilepsihospitalet in Dianalund].
Línnet K
Ugeskr Laeger; 2004 Jan; 166(1-2):70-1; author reply 71. PubMed ID: 14752999
[No Abstract] [Full Text] [Related]
2. [Therapeutic monitoring of psychotropic drugs and pharmacogenetic tests in psychiatry].
Voirol P; Eap CB; Baumann P
Rev Med Suisse Romande; 2000 Feb; 120(2):99-104. PubMed ID: 10748694
[No Abstract] [Full Text] [Related]
3. [CYP genotyping in psychopharmacological treatment].
Bramness JG
Tidsskr Nor Laegeforen; 2006 Feb; 126(4):480; author reply 480. PubMed ID: 16477294
[No Abstract] [Full Text] [Related]
4. [CYP genotyping in psychopharmacological treatment].
Rudberg I; Solberg DK; Refsum H
Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2953-5. PubMed ID: 16276380
[No Abstract] [Full Text] [Related]
5. The potential of genotyping.
de Leon J
Science; 2008 Aug; 321(5890):769. PubMed ID: 18687938
[No Abstract] [Full Text] [Related]
6. Personalized drug therapy with pharmacogenetics. Part 1: Pharmacokinetics.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2006 Jan; 44(1):13-6. PubMed ID: 16475439
[No Abstract] [Full Text] [Related]
7. [Genetic tests give the finishing touch to individual drug dosage].
Sjöqvist F
Lakartidningen; 2003 Feb; 100(8):592-3. PubMed ID: 12640970
[No Abstract] [Full Text] [Related]
8. [Pharmacogenetics--pathway to individualized antihypertensive pharmacotherapy].
Kurland L; Lind L; Lithell H; Syvänen AC; Melhus H
Lakartidningen; 2003 Feb; 100(8):600-3. PubMed ID: 12640971
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics and lung transplantation: clinical implications.
Burckart GJ; Hutchinson IV; Zeevi A
Pharmacogenomics J; 2006; 6(5):301-10. PubMed ID: 16520825
[No Abstract] [Full Text] [Related]
10. [Psychopharmacologic outpatient clinics].
Solberg DK; Haslemo T; Refsum H
Tidsskr Nor Laegeforen; 2012 May; 132(9):1065-7. PubMed ID: 22614303
[No Abstract] [Full Text] [Related]
11. Is genetic testing for cytochrome P450 polymorphisms ready for implementation?
Matchar DB; Thakur M
Am Fam Physician; 2007 Aug; 76(3):348, 351. PubMed ID: 17708133
[No Abstract] [Full Text] [Related]
12. Therapeutic drug monitoring of psychotropic medications.
Mitchell PB
Br J Clin Pharmacol; 2001; 52 Suppl 1(Suppl 1):45S-54S. PubMed ID: 11564052
[TBL] [Abstract][Full Text] [Related]
13. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Lynch T; Price A
Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs.
Anderson GD
Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977
[TBL] [Abstract][Full Text] [Related]
15. CYP450 pharmacogenetics for personalizing cancer therapy.
van Schaik RH
Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
[TBL] [Abstract][Full Text] [Related]
16. Gene-based drug prescribing: clinical implications of the cytochrome P450 genes.
Musana AK; Wilke RA
WMJ; 2005 Aug; 104(6):61-6. PubMed ID: 16218319
[TBL] [Abstract][Full Text] [Related]
17. Genetic factors in drug metabolism.
Belle DJ; Singh H
Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics-guided dose modifications of antidepressants.
Seeringer A; Kirchheiner J
Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic testing in schizophrenia and posttraumatic stress disorder.
Ramey-Hartung B; El-Mallakh RS; Reynolds KK
Clin Lab Med; 2008 Dec; 28(4):627-43. PubMed ID: 19059067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
